Researchers discover a new cancer-driving mutation in 'dark matter' of the cancer genome

by Ontario Institute for Cancer ResearchCredit: CC0 Public DomainAn Ontario-led research group has discovered a novel cancer-driving mutation in the vast non-coding regions of the human cancer genome,

Updated on: June 04,2024

Researchers discover a new cancer-driving mutation in 'dark matter' of the cancer genome

by Ontario Institute for Cancer ResearchCredit: CC0 Public DomainAn Ontario-led research group has discovered a novel cancer-driving mutation in the vast non-coding regions of the human cancer genome,

Updated on:June 04,2024

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from

Updated on: January 29,2024

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from

Updated on:January 29,2024

Researchers identify targeted therapy that can help children with deadly nerve cancer

by The Mount Sinai HospitalCredit: CC0 Public DomainMount Sinai researchers have identified a targeted therapy for adolescent patients with neuroblastoma, a deadly pediatric nerve cancer, who wou

Updated on: June 08,2024

Researchers identify targeted therapy that can help children with deadly nerve cancer

by The Mount Sinai HospitalCredit: CC0 Public DomainMount Sinai researchers have identified a targeted therapy for adolescent patients with neuroblastoma, a deadly pediatric nerve cancer, who wou

Updated on:June 08,2024

Ophthalmologic manifestations of acute leukemia are heterogeneous

by Elana GotkineOphthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a studypublishedonline July 10 in the&nbsp

Updated on: August 03,2024

Ophthalmologic manifestations of acute leukemia are heterogeneous

by Elana GotkineOphthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a studypublishedonline July 10 in the&nbsp

Updated on:August 03,2024

Fewer lymph node operations for breast cancer patients with new prediction models

by Lund UniversityCredit: MostphotosIn recently published studies, researchers at Lund University and Skåne University Hospital in Sweden have produced new prediction models for improved personal

Updated on: March 01,2024

Fewer lymph node operations for breast cancer patients with new prediction models

by Lund UniversityCredit: MostphotosIn recently published studies, researchers at Lund University and Skåne University Hospital in Sweden have produced new prediction models for improved personal

Updated on:March 01,2024

App an effective tool to record sun exposure

by Queensland University of TechnologyCredit: Queensland University of TechnologyA smartphone app is an accessible tool that reliably measures the amount of exposure to the sun's skin-damagin

Updated on: March 30,2024

App an effective tool to record sun exposure

by Queensland University of TechnologyCredit: Queensland University of TechnologyA smartphone app is an accessible tool that reliably measures the amount of exposure to the sun's skin-damagin

Updated on:March 30,2024

Certain gene signaling rewires tumors after immunotherapy

by Anna Megdell,University of MichiganGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2022.12.008Researchers from the University of Michigan Rogel Cancer Center ha

Updated on: January 02,2024

Certain gene signaling rewires tumors after immunotherapy

by Anna Megdell,University of MichiganGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2022.12.008Researchers from the University of Michigan Rogel Cancer Center ha

Updated on:January 02,2024

Targeted therapy better for repeat kidney cancer patients than FDA-approved counterpart

by City of HopeKiller T cells surround a cancer cell. Credit: NIHKidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression wi

Updated on: April 14,2024

Targeted therapy better for repeat kidney cancer patients than FDA-approved counterpart

by City of HopeKiller T cells surround a cancer cell. Credit: NIHKidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression wi

Updated on:April 14,2024

Promotion of cancer progression via extracellular vesicles

by Tokyo Medical and Dental UniversityUsually, blood vessels are stabilized, and their barrier function is maintained by the tight adhesion between vascular endothelial cells (①). When cancer cells me

Updated on: January 07,2024

Promotion of cancer progression via extracellular vesicles

by Tokyo Medical and Dental UniversityUsually, blood vessels are stabilized, and their barrier function is maintained by the tight adhesion between vascular endothelial cells (①). When cancer cells me

Updated on:January 07,2024

Potential strategy for treating liver cancer: Study discovers signaling pathway mediated by extracellular vesicles

by The University of Hong KongCirculating sEVs from HCC patients promote angiogenesis in vitro and in vivo. A) Tube formation assay of HUVECs pretreated with PBS, circulating sEVs of control indi

Updated on: February 18,2024

Potential strategy for treating liver cancer: Study discovers signaling pathway mediated by extracellular vesicles

by The University of Hong KongCirculating sEVs from HCC patients promote angiogenesis in vitro and in vivo. A) Tube formation assay of HUVECs pretreated with PBS, circulating sEVs of control indi

Updated on:February 18,2024

Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

by Bob Yirka , Medical XpressCAR T Cell Concentrations Stratified by Response. (a) CAR T cell concentrations among ALLO-715 DL3 patients that received any fludarabine/cyclophosphamide/ALLO-647 (FCA) l

Updated on: February 03,2024

Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

by Bob Yirka , Medical XpressCAR T Cell Concentrations Stratified by Response. (a) CAR T cell concentrations among ALLO-715 DL3 patients that received any fludarabine/cyclophosphamide/ALLO-647 (FCA) l

Updated on:February 03,2024

Research finds unexpected link between chromosomal instability and epigenetic alterations

by Ian Demsky,Memorial Sloan Kettering Cancer CenterThe two colored dots outside of this breast cancer cell's primary nucleus indicate the presence of micronuclei. A new study investigated h

Updated on: January 29,2024

Research finds unexpected link between chromosomal instability and epigenetic alterations

by Ian Demsky,Memorial Sloan Kettering Cancer CenterThe two colored dots outside of this breast cancer cell's primary nucleus indicate the presence of micronuclei. A new study investigated h

Updated on:January 29,2024